跳至主要内容
临床试验/NCT06306742
NCT06306742已完成2 期

Open-label Placebo in Manual Therapies: a Pilot Study.

Studio Osteopatico Busto Arsizio2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2024年2月26日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
31
试验地点
2
主要终点
Change in Numeric Rating Scale

研究概览

简要总结

to investigate the effects of placebo in patients affected by low-back pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (+18 years) who complain of chronic non-specific low back pain for at least 3 months with or without pain exacerbations at the time of recruitment, will be included.
  • Patients will need to have a diagnosis of low back pain made by a physician

排除标准

  • pathologies such as ankylosing spondylitis, infections, fractures, tumors or metastases.
  • Pregnant women
  • patients with previous spinal surgery or undergoing cortisone therapy in the 6 months prior to the trial
  • diseases that may affect the interpretation of results such as fibromyalgia
  • patients currently being treated by other specialists or other manual therapists

研究组 & 干预措施

OMT

Active Comparator

Participants will receive manual treatments. The treatment will include soft-tissue, joint mobilization techniques of the lumbar and sacral region. The treatment will also include the approach of the abdomen and lower limb with the same type of techniques.

Four treatments will be provided at 1, 2, 4 and 8 weeks.

干预措施: Osteopathic manipulative treatment (Other)

Waiting list

No Intervention

Participants will receive no treatment.

Open-label placebo

Experimental

This group will receive an open-label placebo. The manual treatment will be performed in the same areas of the active comparator but using a very light pressure. Additionally, before the start of the treatment, Four treatments will be provided at 1, 2, 4 and 8 weeks.

干预措施: Open-label placebo (Other)

结局指标

主要结局

Change in Numeric Rating Scale

时间窗: Change from baseline of numeric rating scale at week 2, 4 and 8.

a verbal determination of a pain level on a scale from 0 to 10, in which 0 represents no pain and 10 represents excruciating pain.

Adverse effects

时间窗: through study completion (8 weeks)

Number and types of adverse effects occurred after intervention

次要结局

  • Changes in algometer measurements(from baseline at week 2, 4 and 8)
  • Change in measures of Von Frey filaments(from baseline at week 2,4 and 8.)
  • Changes in algometer measurements(from baseline at week 2, 4 and 8)
  • Use of analgesics(The week before the scheduled visit.)

研究者

发起方
Studio Osteopatico Busto Arsizio
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carolina Lavazza

Principal investigator

Studio Osteopatico Busto Arsizio

研究点 (2)

Loading locations...

相似试验

Open-label Placebo in Manual Therapy | 临床试验